Wellington Management Group LLP 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 3:00 pm Sale | 2022-12-30 | 13G | Iovance Biotherapeutics, Inc. IOVA | Wellington Management Group LLP | 421,610 0.270% | -9,162,472 (-95.60%) | Filing |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Wellington Management Group LLP | 9,584,082 6.110% | 9,584,082 (New Position) | Filing |